244 related articles for article (PubMed ID: 15585847)
1. Regulatory T cell suppression and anergy are differentially regulated by proinflammatory cytokines produced by TLR-activated dendritic cells.
Kubo T; Hatton RD; Oliver J; Liu X; Elson CO; Weaver CT
J Immunol; 2004 Dec; 173(12):7249-58. PubMed ID: 15585847
[TBL] [Abstract][Full Text] [Related]
2. Endotoxin-induced maturation of MyD88-deficient dendritic cells.
Kaisho T; Takeuchi O; Kawai T; Hoshino K; Akira S
J Immunol; 2001 May; 166(9):5688-94. PubMed ID: 11313410
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow-derived dendritic cells reverse the anergic state of CD4+CD25+ T cells without reversing their suppressive function.
Brinster C; Shevach EM
J Immunol; 2005 Dec; 175(11):7332-40. PubMed ID: 16301639
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells.
Gaudreau S; Guindi C; Ménard M; Besin G; Dupuis G; Amrani A
J Immunol; 2007 Sep; 179(6):3638-47. PubMed ID: 17785799
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology.
Higgins SC; Lavelle EC; McCann C; Keogh B; McNeela E; Byrne P; O'Gorman B; Jarnicki A; McGuirk P; Mills KH
J Immunol; 2003 Sep; 171(6):3119-27. PubMed ID: 12960338
[TBL] [Abstract][Full Text] [Related]
6. Differential control of T regulatory cell proliferation and suppressive activity by mature plasmacytoid versus conventional spleen dendritic cells.
Ouabed A; Hubert FX; Chabannes D; Gautreau L; Heslan M; Josien R
J Immunol; 2008 May; 180(9):5862-70. PubMed ID: 18424705
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cells generated with Flt3L and exposed to apoptotic cells lack induction of T cell anergy and Foxp3⁺ regulatory T cell conversion in vitro.
Pletinckx K; Lutz MB
Immunobiology; 2014 Mar; 219(3):230-40. PubMed ID: 24252473
[TBL] [Abstract][Full Text] [Related]
8. IL-10-producing CD4+CD25+ regulatory T cells play a critical role in granulocyte-macrophage colony-stimulating factor-induced suppression of experimental autoimmune thyroiditis.
Gangi E; Vasu C; Cheatem D; Prabhakar BS
J Immunol; 2005 Jun; 174(11):7006-13. PubMed ID: 15905543
[TBL] [Abstract][Full Text] [Related]
9. A newly established murine immature dendritic cell line can be differentiated into a mature state, but exerts tolerogenic function upon maturation in the presence of glucocorticoid.
Bros M; Jährling F; Renzing A; Wiechmann N; Dang NA; Sutter A; Ross R; Knop J; Sudowe S; Reske-Kunz AB
Blood; 2007 May; 109(9):3820-9. PubMed ID: 17209058
[TBL] [Abstract][Full Text] [Related]
10. Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells.
Fehérvári Z; Sakaguchi S
Int Immunol; 2004 Dec; 16(12):1769-80. PubMed ID: 15520045
[TBL] [Abstract][Full Text] [Related]
11. IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation.
Park SJ; Nakagawa T; Kitamura H; Atsumi T; Kamon H; Sawa S; Kamimura D; Ueda N; Iwakura Y; Ishihara K; Murakami M; Hirano T
J Immunol; 2004 Sep; 173(6):3844-54. PubMed ID: 15356132
[TBL] [Abstract][Full Text] [Related]
12. A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells.
Datta SK; Redecke V; Prilliman KR; Takabayashi K; Corr M; Tallant T; DiDonato J; Dziarski R; Akira S; Schoenberger SP; Raz E
J Immunol; 2003 Apr; 170(8):4102-10. PubMed ID: 12682240
[TBL] [Abstract][Full Text] [Related]
13. Combined TLR stimulation with Pam3Cys and Poly I: C enhances Flt3-ligand dendritic cell activation for tumor immunotherapy.
Lim SN; Kuhn S; Hyde E; Ronchese F
J Immunother; 2012; 35(9):670-9. PubMed ID: 23090076
[TBL] [Abstract][Full Text] [Related]
14. Human CD4+CD25high regulatory T cells modulate myeloid but not plasmacytoid dendritic cells activation.
Houot R; Perrot I; Garcia E; Durand I; Lebecque S
J Immunol; 2006 May; 176(9):5293-8. PubMed ID: 16621995
[TBL] [Abstract][Full Text] [Related]
15. Tolerogenic bone marrow-derived dendritic cells induce neuroprotective regulatory T cells in a model of Parkinson's disease.
Schutt CR; Gendelman HE; Mosley RL
Mol Neurodegener; 2018 May; 13(1):26. PubMed ID: 29783988
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity.
Kim WS; Kim H; Kwon KW; Im SH; Lee BR; Ha SJ; Shin SJ
Oncotarget; 2016 Jun; 7(23):33765-82. PubMed ID: 27172902
[TBL] [Abstract][Full Text] [Related]
17. Immature dendritic cells convert anergic nonregulatory T cells into Foxp3- IL-10+ regulatory T cells by engaging CD28 and CTLA-4.
Pletinckx K; Vaeth M; Schneider T; Beyersdorf N; Hünig T; Berberich-Siebelt F; Lutz MB
Eur J Immunol; 2015 Feb; 45(2):480-91. PubMed ID: 25382658
[TBL] [Abstract][Full Text] [Related]
18. Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4.
Weatherill AR; Lee JY; Zhao L; Lemay DG; Youn HS; Hwang DH
J Immunol; 2005 May; 174(9):5390-7. PubMed ID: 15843537
[TBL] [Abstract][Full Text] [Related]
19. Beta 1-integrin ligation and TLR ligation enhance GM-CSF-induced ALDH1A2 expression in dendritic cells, but differentially regulate their anti-inflammatory properties.
Yokota-Nakatsuma A; Ohoka Y; Takeuchi H; Song SY; Iwata M
Sci Rep; 2016 Nov; 6():37914. PubMed ID: 27897208
[TBL] [Abstract][Full Text] [Related]
20. Helminth antigens modulate TLR-initiated dendritic cell activation.
Kane CM; Cervi L; Sun J; McKee AS; Masek KS; Shapira S; Hunter CA; Pearce EJ
J Immunol; 2004 Dec; 173(12):7454-61. PubMed ID: 15585871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
